| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
25,980,000 |
| Market
Cap: |
126.26(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.11 - $38 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
200 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,250 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
231,724 |
319,059 |
891,005 |
891,005 |
| Total Sell Value |
$811,485 |
$1,915,016 |
$14,925,115 |
$14,925,115 |
| Total People Sold |
1 |
4 |
11 |
11 |
| Total Sell Transactions |
13 |
17 |
57 |
57 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tyree James L |
Director |
– • – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
|
- |
|
| Samuelson Doug |
Chief Financial Officer |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,600 |
3,600 |
|
- |
|
| Zhang Qian |
Associate VP, Research |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
139,333 |
|
- |
|
| Cappello Joseph |
VP, Pharmaceutical Development |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
|
- |
|
| Mirabelli Mary |
Director |
– • – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
1,000 |
|
- |
|
| Woodward Gabe |
Director |
– • – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
4,186 |
|
- |
|
| Ryder Sean |
General Counsel |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
900 |
900 |
|
- |
|
| Thomas John |
Director |
– • – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
470,000 |
470,000 |
|
- |
|
| Szalay Aladar |
10% Owner |
– – • |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,000,000 |
550,000 |
|
- |
|
| Woodward Gabe |
Director |
– • – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
8,176 |
2,798 |
|
- |
|
| Woodward Gabe |
Director |
– • – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,186 |
3,186 |
|
- |
|
| Zhang Qian |
Associate VP, Research |
• – – |
2023-01-26 |
4 |
B |
$6.25 |
$1,250 |
I/I |
200 |
200 |
1.91 |
- |
|
| Yu Tony |
VP, Clinical Trial OperationsO |
• – – |
2023-01-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
150,000 |
|
- |
|
| Zhang Qian |
Associate VP, ResearchOfficer |
• – – |
2023-01-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
133,333 |
|
- |
|
| Szalay Aladar |
10% Owner |
– – • |
2023-01-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,567,831 |
|
- |
|
| Szalay Aladar |
10% Owner |
– – • |
2023-01-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,167 |
|
- |
|
91 Records found
|
|
Page 4 of 4 |
|
|
0.16 (3.19%) 
